PMID- 24669687 OWN - NLM STAT- MEDLINE DCOM- 20140919 LR - 20190221 IS - 2096-7993 (Print) IS - 2096-7993 (Linking) VI - 27 IP - 24 DP - 2013 Dec TI - [The treatment and clinical therapeutic effect analysis in 59 cases of advanced supraglottic laryngeal squamous cell carcinoma]. PG - 1366-9 AB - OBJECTIVE: To compare the therapeutic effect of postoperative radiotherapy with surgery alone in advanced supraglottic laryngeal squamous cell carcinoma (LSCC). METHOD: According to the treatment methods, 59 patients with advanced supraglottic LSCC were divided into surgery plus radiotherapy group (S+R group) (33 cases) and surgical group (S group) (26 cases). In S+R group, total laryngectomy was performed on 27 patients and partial laryngectomy on 6 patients, 27 of whom underwent lateral neck dissections; while in S group, total laryngectomy was performed on 23 patients and partial laryngectomy on 3 patients, 24 of whom underwent lateral neck dissections. RESULT: The 3-year overall survival rate of S+R and S group were 62.6% and 62.6% respectively, and the 5-year overall survival rate of S+R and S group were 43.8% and 40.5% respectively. But there was no statistically significant difference of survival rate between two groups by Log-rank test (P > 0.05). In S+R group, recurrence happened in 5 cases and the recurrent rate was 15.1%; in S group, recurrence happened in 10 patients and the recurrent rate was 38.5%, statistically significant difference was found between the two recurrent rates (P < 0.05). CONCLUSION: Surgery combined with postoperative radiotherapy could not improve the 3-year-or 5-year overall survival rate, but could significantly reduced tumor recurrence rate. FAU - Lai, Qimin AU - Lai Q FAU - Li, Hao AU - Li H LA - chi PT - Comparative Study PT - Journal Article PL - China TA - Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi JT - Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery JID - 101303164 SB - IM MH - Adult MH - Aged MH - Carcinoma, Squamous Cell/pathology/*radiotherapy/*surgery MH - Combined Modality Therapy MH - Female MH - Glottis/pathology MH - Head and Neck Neoplasms/pathology/*radiotherapy/*surgery MH - Humans MH - Laryngeal Neoplasms/pathology/*radiotherapy/*surgery MH - Laryngectomy MH - Male MH - Middle Aged MH - Neck Dissection MH - Squamous Cell Carcinoma of Head and Neck MH - Survival Rate MH - Treatment Outcome EDAT- 2014/03/29 06:00 MHDA- 2014/09/23 06:00 CRDT- 2014/03/28 06:00 PHST- 2014/03/28 06:00 [entrez] PHST- 2014/03/29 06:00 [pubmed] PHST- 2014/09/23 06:00 [medline] PST - ppublish SO - Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2013 Dec;27(24):1366-9.